Amendment Statement of Principles concerning acute lymphoblastic leukaemia No. 37 of 2016 | F2016L00263 |
Amendment Statement of Principles concerning acute myeloid leukaemia (Reasonable Hypothesis) (No. 33 of 2016) | F2016L00250 |
Amendment Statement of Principles concerning acute myeloid leukaemia (Balance of Probabilities) (No. 34 of 2016) | F2016L00251 |
Amendment Statement of Principles concerning anxiety disorder No. 99 of 2016 | F2016L01697 |
Amendment Statement of Principles concerning anxiety disorder No. 100 of 2016 | F2016L01698 |
Amendment Statement of Principles concerning aplastic anaemia No. 31 of 2016 | F2016L00260 |
Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016 | F2016L00267 |
Amendment Statement of Principles concerning chronic lymphocytic leukaemia/small lymphocytic lymphoma No. 38 of 2016 | F2016L00273 |
Amendment Statement of Principles concerning chronic lymphoid leukaemia No. 28 of 2014 | F2014L00303 |
Amendment Statement of Principles concerning chronic obstructive pulmonary disease No. 128 of 2015 | F2015L01687 |
Amendment Statement of Principles concerning chronic obstructive pulmonary disease No. 129 of 2015 | F2015L01688 |
Amendment Statement of Principles concerning depressive disorder (Reasonable Hypothesis) (No. 29 of 2016) | F2016L00257 |
Amendment Statement of Principles concerning depressive disorder (Balance of Probabilities) (No. 30 of 2016) | F2016L00258 |
Amendment Statement of Principles concerning diabetes mellitus No. 88 of 2014 | F2014L01150 |
Amendment Statement of Principles concerning diabetes mellitus No. 89 of 2014 | F2014L01151 |
Amendment Statement of Principles concerning diabetes mellitus No. 27 of 2016 | F2016L00276 |
Amendment Statement of Principles concerning diabetes mellitus No. 28 of 2016 | F2016L00278 |
Amendment Statement of Principles concerning fibrosing interstitial lung disease No. 59 of 2010 | F2010L01672 |
Amendment Statement of Principles concerning fibrosing interstitial lung disease No. 60 of 2010 | F2010L01673 |
Amendment Statement of Principles concerning fibrosing interstitial lung disease No. 79 of 2011 | F2011L00730 |
Amendment Statement of Principles concerning fibrosing interstitial lung disease No. 80 of 2011 | F2011L00732 |
Amendment Statement of Principles concerning fibrosing interstitial lung disease No. 66 of 2012 | F2012L01811 |
Amendment Statement of Principles concerning fibrosing interstitial lung disease No. 67 of 2012 | F2012L01812 |
Amendment Statement of Principles concerning ischaemic heart disease No. 33 of 2014 | F2014L00302 |
Amendment Statement of Principles concerning lipoma (Balance of Probabilities) (No. 115 of 2015) | F2015L01388 |
Amendment Statement of Principles concerning lipoma (Reasonable Hypothesis) (No. 114 of 2015) | F2015L01387 |
Amendment Statement of Principles concerning lumbar spondylosis No. 69 of 2013 | F2013L01657 |
Amendment Statement of Principles concerning lumbar spondylosis No. 70 of 2013 | F2013L01658 |
Amendment Statement of Principles concerning malignant neoplasm of the oesophagus (Reasonable Hypothesis) (No. 21 of 2017) | F2017L00018 |
Amendment Statement of Principles concerning malignant neoplasm of the ovary (Balance of Probabilities) (No. 36 of 2018) | F2018L00184 |
Amendment Statement of Principles concerning malignant neoplasm of the ovary (Reasonable Hypothesis) (No. 35 of 2018) | F2018L00185 |
Amendment Statement of Principles concerning malignant neoplasm of the prostate No. 19 of 2017 | F2017L00017 |
Amendment Statement of Principles concerning malignant neoplasm of the prostate No. 20 of 2017 | F2017L00019 |
Amendment Statement of Principles concerning motor neurone disease No. 53 of 2009 | F2009L02423 |
Amendment Statement of Principles concerning myelodysplastic syndrome (Reasonable Hypothesis) (No. 35 of 2016) | F2016L00252 |
Amendment Statement of Principles concerning myelodysplastic syndrome (Balance of Probabilities) (No. 36 of 2016) | F2016L00253 |
Amendment Statement of Principles concerning myeloma No. 39 of 2016 | F2016L00277 |
Amendment Statement of Principles concerning myeloma No. 72 of 2014 | F2014L00936 |
Amendment Statement of Principles concerning myeloma No. 73 of 2014 | F2014L00935 |
Amendment Statement of Principles concerning non-Hodgkin's lymphoma No. 57 of 2014 | F2014L00485 |
Amendment Statement of Principles concerning non-Hodgkin's lymphoma No. 86 of 2014 | F2014L01148 |
Amendment Statement of Principles concerning non-Hodgkin's lymphoma No. 87 of 2014 | F2014L01149 |
Amendment Statement of Principles concerning non-Hodgkin's lymphoma No. 93 of 2015 | F2015L00933 |
Amendment Statement of Principles concerning non-Hodgkin's lymphoma No. 40 of 2016 | F2016L00280 |
Amendment Statement of Principles concerning otitic barotrauma No. 15 of 2017 | F2017L00009 |
Amendment Statement of Principles concerning otitic barotrauma No. 16 of 2017 | F2017L00011 |
Amendment Statement of Principles concerning panic disorder (No. 101 of 2016) | F2016L01681 |
Amendment Statement of Principles concerning panic disorder (No. 102 of 2016) | F2016L01668 |
Amendment Statement of Principles concerning posttraumatic stress disorder No. 19 of 2014 | F2014L00066 |
Amendment Statement of Principles concerning sinus barotrauma No. 17 of 2017 | F2017L00013 |
Amendment Statement of Principles concerning sinus barotrauma No. 18 of 2017 | F2017L00014 |
Amendment Statement of Principles concerning suicide and attempted suicide (Reasonable Hypothesis) (No. 26 of 2017) | F2017L00174 |
Amendment Statement of Principles concerning suicide and attempted suicide (Balance of Probabilities) (No. 27 of 2017) | F2017L00175 |
Amendment Statement of Principles concerning suicide and attempted suicide (Reasonable Hypothesis) (No. 33 of 2018) | F2018L00207 |
Amendment Statement of Principles concerning suicide and attempted suicide (Balance of Probabilities) (No. 34 of 2018) | F2018L00209 |
